Regentis Biomaterials Ltd. (RGNT): Operating Income

Annual figures by period end, from SEC filings.

-$6.97M
Year ended 2025-12-31
$932.0K2023-12-31: -$1.93M2024-12-31: $932.0K2025-12-31: -$6.97M-$6.97M
2023-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$6.97Mn/m2026-02-27, From 2025-01-01
2024-12-31$932.0Kn/m2026-02-27, From 2024-01-01
2023-12-31-$1.93Mn/a2026-02-27, From 2023-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Orthopedic, Prosthetic & Surgical Appliances & Supplies), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Regentis Biomaterials Ltd. (RGNT)2025-12-31-$6.97Mn/m
NutriBand Inc. (NTRB)2026-01-31-$8.32Mn/m
Milestone Scientific Inc. (MLSS)2025-12-31-$5.70Mn/m
Envoy Medical, Inc. (COCH)2025-12-31-$22.27Mn/m
Bone Biologics Corp (BBLG)2025-12-31-$3.23Mn/m
CollPlant Biotechnologies Ltd (OPHI)2025-12-31-$11.48Mn/m
Vicarious Surgical Inc. (RBOT)2025-12-31-$50.03Mn/m
Lifeward Ltd. (LFWD)2025-12-31-$19.67Mn/m
Anteris Technologies Global Corp. (AVR)2025-12-31-$93.89Mn/m

Compare RGNT, NTRB, MLSS, COCH side by side · Screen every company in Orthopedic, Prosthetic & Surgical Appliances & Supplies ↗